A Phase II Evaluation of Avastin in Combination With Docetaxel and Carboplatin as Chemotherapy in Patients With Metastatic Non-Small Cell Lung Cancer.
Phase of Trial: Phase II
Latest Information Update: 07 Aug 2017
At a glance
- Drugs Bevacizumab (Primary) ; Carboplatin (Primary) ; Docetaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 01 Aug 2017 Status changed from active, no longer recruiting to completed.
- 26 Apr 2017 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
- 25 Apr 2016 Planned primary completion date changed from 1 Dec 2016 to 1 Dec 2017.